RHBDL1 Inhibitors
RHBDL1 inhibitors belong to a distinct chemical class characterized by their ability to modulate the activity of the Rhomboid-like protein 1 (RHBDL1). RHBDL1 is a member of the rhomboid protease family, enzymes that play pivotal roles in intramembrane proteolysis. Specifically, RHBDL1 is involved in the cleavage of various substrates within the lipid bilayer of cellular membranes. This enzymatic function is crucial for the regulation of key cellular processes, including signal transduction, protein trafficking, and cell adhesion. The inhibitors of RHBDL1 are designed to selectively impede the catalytic activity of this protease, thereby influencing the processing of its substrates.
RHBDL1 inhibitors are often designed based on the three-dimensional configuration of the active site of RHBDL1. These compounds typically possess specific chemical moieties that interact with key residues within the catalytic pocket of RHBDL1, disrupting its enzymatic activity. The development of RHBDL1 inhibitors represents a significant advancement in understanding the intricate regulatory mechanisms of intramembrane proteolysis. Researchers are actively exploring the potential applications of these inhibitors in various biological contexts to unravel the specific cellular pathways governed by RHBDL1. As the understanding of the complex interplay between RHBDL1 and its substrates deepens, the design and optimization of RHBDL1 inhibitors continue to be an area of active investigation in the field of molecular and cell biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E64 is a potent, irreversible cysteine protease inhibitor that can inhibit a broad range of cysteine proteases. It could affect RHBDL1 activity by inhibiting related proteases that may regulate its biological function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a potent, reversible proteasome and calpain inhibitor. By inhibiting the proteasome, it can lead to the accumulation of proteins, which could in turn influence RHBDL1's activity or expression. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Lactacystin is a specific inhibitor of the proteasome. Similar to MG132, it can affect cellular proteolytic systems, which may alter the functional context of RHBDL1. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin is a small protein protease inhibitor that inhibits several serine proteases. Its use can affect proteolytic pathways, which might influence the function of RHBDL1. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Z-VAD-FMK is a pan-caspase inhibitor that can block apoptotic pathways. By inhibiting caspases, it might affect cell survival pathways, potentially impacting RHBDL1 indirectly. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
Gabexate is an inhibitor of serine proteases, particularly those involved in the fibrinolytic system. Its effects on protease activity could alter cellular processes that may involve RHBDL1. | ||||||
Nelfinavir | 159989-64-7 | sc-507314 | 10 mg | $168.00 | ||
Nelfinavir is known primarily as an HIV protease inhibitor, but it also has been found to inhibit some cellular proteases. This could influence the activity or regulation of RHBDL1. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpeptin is a calpain inhibitor. By inhibiting calpain, it can modify the intracellular signaling pathways, possibly affecting RHBDL1 function. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone is a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist. It is included here for its potential to influence signaling pathways that may indirectly modulate RHBDL1. | ||||||